The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 4, Pages 8213-8227
Publisher
MDPI AG
Online
2013-04-16
DOI
10.3390/ijms14048213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
- (2015) Ramandeep Rattan et al. NEOPLASIA
- MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas
- (2013) Yu-Quan Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
- (2013) Y Xiang et al. ONCOGENE
- sMEK1 enhances gemcitabine anti-cancer activity through inhibition of phosphorylation of Akt/mTOR
- (2012) Hyun-Jung Byun et al. APOPTOSIS
- Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer
- (2012) E. Kobayashi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
- (2012) T. Shimizu et al. CLINICAL CANCER RESEARCH
- Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
- (2012) Xin Fu et al. FEBS LETTERS
- Oral Administration of Apigenin Inhibits Metastasis through AKT/P70S6K1/MMP-9 Pathway in Orthotopic Ovarian Tumor Model
- (2012) Jun He et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice
- (2012) Kathryn M. Kinross et al. JOURNAL OF CLINICAL INVESTIGATION
- Predominance of mTORC1 over mTORC2 in the Regulation of Proliferation of Ovarian Cancer Cells: Therapeutic Implications
- (2012) Juan Carlos Montero et al. MOLECULAR CANCER THERAPEUTICS
- The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer
- (2012) C. P. Carden et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors
- (2012) Meng Gong et al. NEURO-ONCOLOGY
- Inhibition of EGFR-AKT Axis Results in the Suppression of Ovarian Tumors In Vitro and in Preclinical Mouse Model
- (2012) Sivakumar Loganathan et al. PLoS One
- Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization
- (2012) J. Saadi Imam et al. PLoS One
- High-grade serous ovarian cancer arises from fallopian tube in a mouse model
- (2012) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Staying Alive: PI3K Pathway Promotes Primordial Follicle Activation and Survival in Response to 3MC-Induced Ovotoxicity
- (2012) Alexander P. Sobinoff et al. TOXICOLOGICAL SCIENCES
- Dissecting “PI3Kness”: The Complexity of Personalized Therapy for Ovarian Cancer
- (2012) Robert C. Bast et al. Cancer Discovery
- GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer
- (2012) Satoe Fujiwara et al. Journal of Ovarian Research
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Akt2 Regulates All Akt Isoforms and Promotes Resistance to Hypoxia through Induction of miR-21 upon Oxygen Deprivation
- (2011) C. Polytarchou et al. CANCER RESEARCH
- Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma
- (2011) R. Wu et al. CLINICAL CANCER RESEARCH
- Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma
- (2011) C. Santiskulvong et al. CLINICAL CANCER RESEARCH
- Inhibiting the mTOR Pathway Synergistically Enhances Cytotoxicity in Ovarian Cancer Cells Induced by Etoposide through Upregulation of c-Jun
- (2011) H. Itamochi et al. CLINICAL CANCER RESEARCH
- Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome
- (2011) Jia Huang et al. GENES CHROMOSOMES & CANCER
- Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1
- (2011) T.K.H. Chung et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting AMPK in the treatment of malignancies
- (2011) Eliza Vakana et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Blockade of Fatty Acid Synthase Induces Ubiquitination and Degradation of Phosphoinositide-3-Kinase Signaling Proteins in Ovarian Cancer
- (2011) K. Tomek et al. MOLECULAR CANCER RESEARCH
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- The G-protein-coupled estrogen receptor GPER in health and disease
- (2011) Eric R. Prossnitz et al. Nature Reviews Endocrinology
- Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis
- (2011) W. Glenn McCluggage PATHOLOGY
- MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein
- (2010) Lou INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Status of PI3K inhibition and biomarker development in cancer therapeutics
- (2009) B. Markman et al. ANNALS OF ONCOLOGY
- Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway
- (2009) Yin-Yan He et al. CANCER SCIENCE
- DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
- (2009) Timothy R. Peterson et al. CELL
- In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
- (2009) K. P. Hoeflich et al. CLINICAL CANCER RESEARCH
- Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
- (2009) Deo Prakash Pandey et al. EMBO JOURNAL
- GPR30 predicts poor survival for ovarian cancer
- (2009) Harriet O. Smith et al. GYNECOLOGIC ONCOLOGY
- Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance
- (2008) N. T. Ihle et al. CANCER RESEARCH
- The cell of origin of ovarian epithelial tumours
- (2008) Louis Dubeau LANCET ONCOLOGY
- The PTEN–PI3K pathway: of feedbacks and cross-talks
- (2008) A Carracedo et al. ONCOGENE
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
- (2008) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now